Unlocking the Power of Genomics: An Interview with Genetic Technologies' CEO Simon Morriss

Genetic Technologies Limited (Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products. Learn more at www.genetechinfo.com.

0:00 - Start
0:05 - Company Overview
1:10 - Market Opportunity
1:58 - Planned Pilot Program
2:45 - Business Model
3:44 - Management Team
5:08 - Value Proposition